FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease

The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.